OncoTargets and Therapy
Volume 9, 2016 - Issue
Open access
59
Views
23
CrossRef citations to date
0
Altmetric
Review
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
Jacqueline C BarrientosCLL Research and Treatment Program, Division of Hematology/Oncology, Department of Medicine, Hofstra Northwell School of Medicine, Hofstra University, Lake Success, NY, USACorrespondence[email protected]
Pages 2945-2953
|
Published online: 18 May 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.